These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23865431)

  • 41. [Surveillance of patients with Barrett's esophagus].
    Endlicher E; Knüchel R; Messmann H
    Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dysplastic Barrett's esophagus in scleroderma.
    Sprung DJ; Gibb SP
    Am J Gastroenterol; 1985 Jul; 80(7):518-22. PubMed ID: 4014100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus.
    Del Portillo A; Lagana SM; Yao Y; Uehara T; Jhala N; Ganguly T; Nagy P; Gutierrez J; Luna A; Abrams J; Liu Y; Brand R; Sepulveda JL; Falk GW; Sepulveda AR
    J Mol Diagn; 2015 Jul; 17(4):412-9. PubMed ID: 26068095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk for esophageal neoplasia in Barrett's esophagus patients with mucosal changes indefinite for dysplasia.
    Horvath B; Singh P; Xie H; Thota PN; Allende DS; Pai RK; Patil DT; Plesec TP; Goldblum JR; Liu X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):262-7. PubMed ID: 25087917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.
    Kestens C; Siersema PD; Offerhaus GJ; van Baal JW
    PLoS One; 2016; 11(5):e0155754. PubMed ID: 27191723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignant progression in Barrett's esophagus: pathology and molecular biology.
    Mueller J; Werner M; Siewert JR
    Recent Results Cancer Res; 2000; 155():29-41. PubMed ID: 10693236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recurrent columnar-lined esophageal segments--study of the phenotypic characteristics using intestinal markers.
    Chaves P; Pereira AD; Cruz C; Suspiro A; Mendes de Almeida JC; Leitão CN; Soares J
    Dis Esophagus; 2002; 15(4):282-6. PubMed ID: 12472472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular biology of Barrett's cancer.
    Atherfold PA; Jankowski JA
    Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin promotes HER2 signaling activation during Barrett's Esophagus carcinogenesis.
    Arcidiacono D; Antonello A; Fassan M; Nucci D; Morbin T; Agostini M; Nitti D; Rugge M; Alberti A; Battaglia G; Realdon S
    Dig Liver Dis; 2017 Jun; 49(6):630-638. PubMed ID: 28185837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma.
    Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV
    Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pathogenesis of Barrett's esophagus--new findings in the experimental studies of duodenal reflux models].
    Hattori T; Mukaisho K; Miwa K
    Nihon Rinsho; 2005 Aug; 63(8):1341-9. PubMed ID: 16101219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
    Majka J; Rembiasz K; Migaczewski M; Budzynski A; Ptak-Belowska A; Pabianczyk R; Urbanczyk K; Zub-Pokrowiecka A; Matlok M; Brzozowski T
    J Physiol Pharmacol; 2010 Aug; 61(4):409-18. PubMed ID: 20814068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surgical options and outcomes in Barrett's esophagus.
    Zaninotto G; Rizzetto C
    Curr Opin Gastroenterol; 2007 Jul; 23(4):452-5. PubMed ID: 17545785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma.
    Kalatskaya I
    Ann N Y Acad Sci; 2016 Oct; 1381(1):74-91. PubMed ID: 27415609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Barrett's esophagus].
    Kawano T; Iwai T
    Nihon Rinsho; 2000 Sep; 58(9):1903-7. PubMed ID: 11004824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel findings in the pathogenesis of esophageal columnar metaplasia or Barrett's esophagus.
    Krishnadath KK
    Curr Opin Gastroenterol; 2007 Jul; 23(4):440-5. PubMed ID: 17545783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biomarkers for Barrett's esophagus - a contemporary review.
    Qureshi AP; Stachler MD; Haque O; Odze RD
    Expert Rev Mol Diagn; 2018 Nov; 18(11):939-946. PubMed ID: 30345836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.